Target Information

Content Navigation (  All   None )                                      
Target General Information
Drugs and Modes of Action
Different Human System Profiles of Target
Target Profiles in Patients
References
Different Human System Profiles of Target  Top
Human Similarity Proteins of target is determined by comparing the sequence similarity of all human proteins with the target based on BLAST. The similarity proteins for a target are defined as the proteins with E-value < 0.005 and outside the protein families of the target.
A target that has fewer human similarity proteins outside its family is commonly regarded to possess a greater capacity to avoid undesired interactions and thus increase the possibility of finding successful drugs (Brief Bioinform, 21: 649-662, 2020).
Human Tissue Distribution of target is determined from a proteomics study that quantified more than 12,000 genes across 32 normal human tissues. Tissue Specificity (TS) score was used to define the enrichment of target across tissues.
The distribution of targets among different tissues or organs need to be taken into consideration when assessing the target druggability, as it is generally accepted that the wider the target distribution, the greater the concern over potential adverse effects (Nat Rev Drug Discov, 20: 64-81, 2021).
Human Similarity Proteins
Human Tissue Distribution
Protein Name Pfam ID Percentage of Identity (%) E value
Melanoma-associated antigen C2 (MAGEC2) 69.008 (167/242) 1.39E-109
Putative MAGE domain-containing protein MAGEA13P (MAGEA13P)
PF12440
50.213 (118/235) 1.85E-68
Melanoma-associated antigen 9 (MAGEA9; MAGEA9B)
PF12440
50.704 (108/213) 1.93E-67
Melanoma-associated antigen C3 (MAGEC3) 52.245 (128/245) 3.04E-63
Note: If a protein has TS (tissue specficity) scores at least in one tissue >= 2.5, this protein is called tissue-enriched (including tissue-enriched-but-not-specific and tissue-specific). In the plots, the vertical lines are at thresholds 2.5 and 4.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.